VLRB antibodies: advances in screening, molecular engineering, and application

Daiyun Zhang1, Pengcheng Li1, Bo Li2

  • 1College of Life Sciences, Liaoning Normal University, Dalian, 116081, China; Lamprey Research Center, Liaoning Normal University, Dalian, 116081, China.

Life Sciences
|October 10, 2025
PubMed
Summary

Variable lymphocyte receptor B (VLRB) antibodies offer unique advantages over conventional immunoglobulins. Their distinct structure and versatile applications in diagnostics, therapeutics, and biomolecular engineering are driving innovation in adaptive immunity research.

Related Concept Videos